Abstract: An attention ability test device includes a display having a display area, an input device for receiving an operation performed by an examinee, and a test controller. While displaying a central image in the central area of the display area and displaying one or more peripheral images in the peripheral area of the display area, the test controller generates at random at least one of a center task of changing the central image and a periphery task of changing the peripheral image, and measures, as a reaction time, the period of time from generation of the center task or the periphery task to execution of a predetermined operation performed by the examinee having recognized the generation, and evaluates the attention ability of the examinee, based on the reaction time.

Abstract: A method for manufacturing a zeolite membrane structure comprises an immersion step for immersing a porous substrate in a synthetic sol, and a synthesis step for hydrothermally synthesizing a zeolite membrane on a surface of the porous substrate that has been immersed in the synthesis so. When the foamability of the synthetic sol is measured by a Ross-Miles method under a condition of 25 degrees C., the foam height after elapse of 5 minutes from completion of down flow is less than or equal to 5 mm.

Abstract: A housing of a scroll type expansion machine includes: a suction port formed at a position on the opposite side to a drive shaft with a fixed scroll interposed therebetween; a discharge port formed on the side of a drive-side bearing closer to the tip end of the drive shaft; a low pressure chamber formed on the outer side of an orbiting-side scroll portion when viewed from the axial direction of the drive shaft; and a tip end-side low-pressure space being a space in which a sealing member is disposed, and has: a partition wall partitioning the tip end-side low-pressure space and the low-pressure chamber from each other; and a communication space communicating the tip end-side low-pressure space with the low-pressure chamber.

Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: A method for forming a carbon-carbon bond, wherein a reaction is performed by filling a platinum group metal-supported catalyst into a filling container, and passing a raw material liquid through the platinum group metal-supported catalyst in a continuous circulation manner, and wherein the platinum group metal-supported catalyst is a platinum group metal-supported catalyst in which nanoparticles of a platinum group metal with an average particle diameter of 1 to 100 nm are supported on a non-particulate organic porous ion exchanger formed of a continuous framework phase and a continuous pore phase.

Abstract: A method for recovering an acidic gas, includes: a step of bringing a gas to be treated that contains an acidic gas into gas-liquid into contact with an amine absorbing solution, allowing the amine absorbing solution to absorb the acidic gas, thereby removing the acidic gas from the gas to be treated; a step of allowing the amine absorbing solution that has absorbed the acidic gas to release the acidic gas, thereby regenerating the amine absorbing solution, and at the same time, recovering the released acidic gas; and an analysis step of calculating concentrations of iron ions and/or heavy metal ions in the amine absorbing solution.

Abstract: A motor control apparatus includes a motor, a motor driver to drive the motor, a motor current detection unit, a motor state estimation unit, a motor control unit, and first and second abnormality detection units. The motor current detection unit detects a current value of the motor. The motor state estimation unit estimates a state of the motor based on a voltage applied to the motor and the detected current value. The motor control unit applies a driving voltage of first driving corresponding to the estimated state of the motor or apply a driving voltage of second driving, which does not use the estimated motor state, to the motor driver. The first abnormality detection unit detects a rotation abnormality of the motor based on the estimated motor state. The second abnormality detection unit detects the rotation abnormality of the motor based on the detected current value of the motor.

Abstract: Provided is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.

Abstract: A model generating part generates an analysis model for an airflow analysis of an indoor space. A temperature distribution estimating part performs the airflow analysis of the indoor space by using the analysis model and estimates a temperature distribution in the indoor space. A communication part acquires a temperature measured at a measurement point in the indoor space. A model correcting part collates the temperature distribution estimated by the temperature distribution estimating part with the temperature at the measurement point acquired by the communication part, and corrects the analysis model based on a collation result.

Abstract: The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of dementia and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.

Abstract: In a variable displacement compressor 100, transmitting member 116 transmits rotational motion of rotor 112 to swash plate 111 and supports swash plate 111. Guide member 117 guides inclining motion of swash plate 111 such that a top dead center position of piston 126 is maintained to be substantially constant. Members 116, 117 are separately formed at different portions on a rotor end face 112a. In the variable displacement compressor 100, first contacted member 118 contacted with transmitting member 116, and second contacted member 119 contacted with guide member 117, are separately formed at different portions on swash plate end face 111b. The transmitting member 116 and the first contacted member 118 extend on rotor 112 and swash plate 111, respectively, from a top dead center side region V1 to a bottom dead center side region V2 of the piston.

Abstract: A housing of a scroll type expansion machine includes: a suction port formed at a position on the opposite side to a drive shaft with a fixed scroll interposed therebetween; a discharge port formed on the side of a drive-side bearing closer to the tip end of the drive shaft; a low pressure chamber formed on the outer side of an orbiting-side scroll portion when viewed from the axial direction of the drive shaft; and a tip end-side low-pressure space being a space in which a sealing member is disposed, and has: a partition wall partitioning the tip end-side low-pressure space and the low-pressure chamber from each other; and a communication space communicating the tip end-side low-pressure space with the low-pressure chamber.

Abstract: A container has a sample installation unit and an NMR circuit therein, and is connected to a bearing gas supply path and a drive gas supply path for supplying gas to the inside of that container. This container is also connected to an exhaust path that exhausts the gas from the inside of the container. The exhaust path has a pressure control valve as an adjustment mechanism for adjusting the pressure in the container.

Abstract: A motor control apparatus includes a motor, a motor driver to drive the motor, a motor current detection unit, a motor state estimation unit, a motor control unit, and first and second abnormality detection units. The motor current detection unit detects a current value of the motor. The motor state estimation unit estimates a state of the motor based on a voltage applied to the motor and the detected current value. The motor control unit applies a driving voltage of first driving corresponding to the estimated state of the motor or apply a driving voltage of second driving, which does not use the estimated motor state, to the motor driver. The first abnormality detection unit detects a rotation abnormality of the motor based on the estimated motor state. The second abnormality detection unit detects the rotation abnormality of the motor based on the detected current value of the motor.

Abstract: Attenuation of microwaves is reduced or prevented when vacuum windows are provided in microwave waveguides of a DNP-NMR probe. A DNP-NMR probe has an inner container and an outer container. The inner container has therein a sample tube containing a sample to which radicals are added. The outer container keeps a space between the outer container and the inner container in the outer container in a vacuum state. The outer container has an outer container waveguide that has a vacuum window at an inner end portion and guides microwaves. The inner container has a vacuum window facing the vacuum window of the outer container waveguide through vacuum, and guides microwaves transmitted from the outer container waveguide to the sample. The window-to-window distance between the vacuum window of the outer container and the vacuum window of the inner container is adjusted by means of adjustment bolts.

Abstract: A zeolite membrane structure includes a porous support, and a zeolite membrane. The zeolite membrane has a first zeolite layer located in a surface of the porous support, and a second zeolite layer located outside of the surface of the porous support and integrally formed with the first zeolite layer. The porous support has an outermost layer in which the first zeolite layer is located. An average thickness of the first zeolite layer is less than or equal to 5.4 micrometers. A porosity of the outermost layer is greater than or equal to 20% and less than or equal to 60%.

Abstract: A rotor contains a sample. A turbine cap is fitted into an opening of one end of the rotor, and a bottom cap is fitted into an opening of the other end of the rotor. A recess portion is formed in the turbine cap, and a recess portion is formed in the bottom cap. Insert members having a negative linear expansion coefficient are disposed in the recess portions.

Abstract: The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of dementia and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.

Abstract: Provided is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.